After the Covid period, in which pharmaceutical stocks experienced decidedly above-average performances, we witnessed a return to normality, culminating in significant declines.
Since the beginning of the year, outflows from the sector have continued, and despite the historic highs on the stock markets, several stocks are still in difficulty.
So let’s see how one of the most representative stocks is doing, namely Pfizer Inc (NYSE:)
PFIZER
Pfizer Inc. (Pfizer) is a research-focused global biopharmaceutical company. The Company is engaged in the discovery, development, manufacturing, marketing, sales and distribution of biopharmaceutical products. Its global portfolio includes medicines and vaccines. It offers therapeutic products in gastroenterology, dermatology and cardiology, including etrasimod, an oral selective sphingosine 1-phosphate (S1P) receptor modulator, in development for a number of immuno-inflammatory diseases, including ulcerative colitis, Crohn’s disease , atopic dermatitis, eosinophilic esophagitis and alopecia areata. The Company operates in all markets to develop well-being, prevention, treatments and cures. Collaborates with healthcare providers, governments and local communities to support and provide access to healthcare. The Company’s drugs and vaccines provide value to healthcare professionals and patients through the treatment of disease, improvement of health and wellness.
Like many pharmaceutical stocks, Pfizer suffered a significant reduction in profits post-covid, although in the last 2 quarters it has returned to earnings and there seems to be an important trend reversal.
The stock has lost over 50% from its highs, but here too in recent weeks there seems to be a reversal which, however, has yet to be confirmed.
The state of health is 3 out of 5, precisely because a return to growth is necessary to aim for an improvement in the indicator.
To date, the stock is undervalued by analysts who indicate a target of 31.92 Dollars, but do fundamentals and mathematics also judge it this way? What could be the Fair Value of the stock? Find out with InvestingPRO+
⚠️ DISCOVER ALL THE DATA ON THOUSANDS OF STOCKS IN REAL TIME: Go Pro: Sign up here, now for less than a coffee a day! In this link you can directly apply the coupon for an additional discount and discover the unique opportunities on the market before anyone else. ⚠️
Will the stock be able to reverse the trend? Much will depend on the economic impact of the new anti-tumor treatments, which currently appear to be able to bring the company back to profitable levels.
“This article was written for information purposes only; it does not constitute a solicitation, offer, advice, consultancy or investment recommendation as such it is not intended to encourage the purchase of assets in any way. I would like to remind you that any type of asset is evaluated from multiple points of view and is highly risky and therefore, every investment decision and the related risk remains with the investor. The author owns shares of the company mentioned”.
